6533b861fe1ef96bd12c535c
RESEARCH PRODUCT
“OXXEL (oxaliplatin plus Xeloda) vs OXAFAFU (oxaliplatin plus folinic acid-modulated 5-fluorouracil i.v. bolus) every 2 weeks in metastatic colorectal carcinoma (MCC): preliminary safety and activity analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial”
Comella PFilippelli GMassidda BPutzu CNatale DMaiorino LCondemi GLeo S. Gambardella A.Sergio Palmerisubject
year | journal | country | edition | language |
---|---|---|---|---|
2006-01-01 |